First Generic Versions of Singulair Approved .


Generic versions of montelukast (marketed as Singulair) have received FDA approval, the agency announced.

The orally administered leukotriene receptor antagonist is used to control symptoms of asthma and allergies, although the FDA warns that montelukast should not be used for relief of sudden asthma attacks. The agency also urges patients to contact clinicians immediately if mood or behavioral changes occur with the drug.

Source: FDA news

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.